Abbott Laboratories is a dividend growth machine that's known for consistency. AbbVie's dividend has more than quadrupled ...

Tremfya snagged Dupixent’s place as the pharma brand with the most TV impressions in June, according to data released by iSpot.tv on Friday morning. The Johnson & Johnson brand garnered a 4.3% share ...

Glenmark Pharmaceuticals shares rallied 10% on Friday to reach a record high after its biotech subsidiary signed a ...

The shares of Glenmark Pharmaceutical Ltd increased 10% on Friday to hit a 52-week high after the company announced that its subsidiary had signed an exclusive license agreement with American ...

Today's rally followed Glenmark's Thursday announcement that its innovation arm, Ichnos Glenmark Innovation (IGI), has ...

Based on the contours of the deal, Motilal Oswal adds an NPV of Rs 470 per share to the 27x 12M forward base business ...

IGI has partnered with AbbVie to grant exclusive rights to globally develop, manufacture, and commercialise ISB 2001 across ...

Trump's moves have raised fears that economic growth would slow to a trickle, if not make the U.S. and other nations more ...

As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy. | As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy ...

During periods of market volatility and economic uncertainty, investors often look for refuge in dependable, dividend-paying ...

AbbVie is on board with the idea. The Big Pharma will pay up to $2.1 billion in cash at closing to acquire Capstan. In return ...